Editorial Commentary | Emerging Therapeutics
Online First
The articles on this page have not yet been scheduled for a specific issue. For published content, please visit Archive.
Editorial Commentary | Clinical Studies
Doravirine/islatravir (DOR-ISL) as a new once-daily oral single-tablet regimen for human immunodeficiency virus (HIV) treatment: unmet need or paradox of choice?
Editorial Commentary | Emerging Therapeutics
Beyond lipid-lowering: convergent immunotherapeutic strategies targeting oxidized low-density lipoprotein in atherosclerosis
Editorial Commentary | Clinical Studies
Sibeprenlimab in IgA nephropathy: does the fairy tale continue in phase 3?
Editorial Commentary | Emerging Medical Technology Innovation and Translation
Beyond virtualization: building resilient perioperative care for aging societies
Editorial Commentary | Clinical Studies
Traumatic optic neuropathy: what does erythropoietin add beyond current therapies
Editorial Commentary | Data Sciences
Clinical application of artificial intelligence-derived myosteatosis measures
Editorial Commentary | Clinical Studies
To stent or not to stent: navigating the complexities of emergent carotid stenting in thrombectomy for stroke due to carotid artery dissection
Editorial Commentary | Clinical Studies
Artificial intelligence-based clinical diagnosis of syncope
Editorial Commentary
Blood markers for Alzheimer’s in Down syndrome as prognostic tools
Editorial Commentary | Data Sciences
Building methodological literacy for clinicians as artificial intelligence enters routine practice: a dermato-oncologic perspective
Editorial Commentary | Emerging Medical Technology Innovation and Translation
Flexible-tip bougies in airway management: experience still matters
Editorial Commentary | Clinical Studies
Adrenocorticotropic hormone analogues for postdural puncture headache: are more studies warranted?
Editorial Commentary | Clinical Studies
Stent, or not to stent: that is the question in acute carotid artery occlusive dissections
Editorial Commentary | Emerging Therapeutics
Leber hereditary optic neuropathy: answers that lead to questions
Editorial Commentary | Emerging Therapeutics
From bench to bedside: the journey of suzetrigine and the future of non-opioid pain management
Editorial Commentary | Clinical Studies
Early vasopressor use in major abdominal surgery: rethinking hemodynamic strategy
Editorial Commentary | Basic and Mechanism Sciences
Mast cells and intestinal barrier dysfunction: dietary triggers, food intolerance/malabsorption, and Helicobacter pylori
Editorial Commentary | Drug and Biomaterials Screening and Development
Radiation-amplified antibody-drug conjugates at the crossroads of innovation and translation
Editorial Commentary | Emerging Therapeutics
Early anatomic disease control with faricimab in neovascular age-related macular degeneration: implications for treat-and-extend care
Editorial Commentary | Emerging Medical Technology Innovation and Translation
Social media-based interventions on improving follow-up attendance and parental education in congenital ectopia lentis
Editorial Commentary | Drug and Biomaterials Screening and Development
Engineering delivery: the rise of transferrin receptor-targeted therapeutics in myotonic dystrophy type 1 and beyond
Editorial Commentary | Clinical Studies
Can ctDNA-guided treatment strategies improve clinical outcomes in esophageal squamous cell carcinoma?
Editorial Commentary | Emerging Therapeutics
Mitapivat in sickle cell disease: a therapeutic setback or a shift in perspective?
Editorial Commentary | Drug and Biomaterials Screening and Development
Beyond metabolic simplicity: lessons from the remimazolam-remifentanil interaction
Editorial Commentary | Clinical Studies
Doravirine/islatravir for maintenance therapy: interpreting emerging evidence and its generalizability
Editorial Commentary | Data-Driven Clinical Practice and Policy Making
Length of storage of packed red blood cell units and risk of acute kidney injury in transfused severely ill patients
Editorial Commentary | Drug and Biomaterials Screening and Development
Morphine versus hydromorphone: when pharmacokinetic variability cannot decide
Editorial Commentary | Emerging Therapeutics
Gene therapy for Bietti crystalline dystrophy: early clinical experience and future directions
Editorial Commentary | Clinical Studies
Continuous versus bolus norepinephrine administration during induction of general anesthesia and blood pressure stability
Editorial Commentary | Emerging Medical Technology Innovation and Translation
Repetitive transcranial magnetic stimulation in fibromyalgia: insights from a multicentre randomised controlled trial
Erratum
Erratum: LncRNA TCONS_00004099-derived microRNA regulates oncogenesis through PTPRF in gliomas
Erratum